Showing results (361-370 of 566) with videos related to

Sort By:
Pageof 57
Cancer|September 26, 2001
Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experienceG Vlastos, N Q Mirza, F Meric, et al.
Cancer|October 18, 2007
Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapyJulia L Oh, Giang Nguyen, Gary J Whitman, et al.
American Journal of Surgery|February 13, 2002
Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinomaH M Kuerer, S E Singletary, A U Buzdar, et al.
The Breast Journal|December 8, 2018
Accelerated partial breast irradiation: Current status with a focus on clinical practiceFabiana A Miranda, Lorine A B Teixeira, Rebeca N Heinzen, et al.
Cancer|June 22, 2010
Population-based analysis of occult primary breast cancer with axillary lymph node metastasisGary V Walker, Grace L Smith, George H Perkins, et al.
Bone Marrow Transplantation|March 28, 2006
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapyN T Ueno, S Konoplev, T A Buchholz, et al.
International Journal of Particle Therapy|November 28, 2019
Variations in Proton Therapy Coverage in the State of Texas: Defining Medical Necessity for a Safe and Effective TreatmentNikhil G Thaker, Ankit Agarwal, Matthew Palmer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitorP J Silver, R L Dundore, D C Bode, et al.
Practical Radiation Oncology|November 22, 2014
Factors associated with radiation therapy incidents in a large academic institutionGary V Walker, Jennifer Johnson, Timothy Edwards, et al.
Breast Cancer Research : BCR|October 1, 2016
Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cellsMatthias Ilmer, Nachman Mazurek, Michael Z Gilcrease, et al.
Pageof 57